U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda ...
A drug for pulmonary fibrosis created using artificial intelligence (AI) is showing early promise in patients.
The Brighterside of News on MSN
New combination drug therapy effectively treats chronic wound infections
Few hospital-acquired infections are as antibiotic-resistant as Pseudomonas aeruginosa. This opportunistic germ has earned a ...
GlobalData on MSN
Turbine and AstraZeneca partner for ADC discovery
Turbine and AstraZeneca have entered a partnership to enhance the discovery of antibody-drug conjugates (ADCs) using the ...
In drug development, that means showing how models are trained, which data are used, and how predictions of safety and ...
The government has rolled out the official document inviting companies to research and develop novel drugs, therapies, and medical devices for one of its most ambitious pharmaceutical R&D ...
A new variant of a deadly synthetic opioid has been detected in Queensland for the first time, just days after it was ...
Academic scientists and pharmaceutical companies alike are embracing artificial intelligence, even as questions linger about ...
AlphaFold 3 (AF3), the latest AI model from Google DeepMind and Isomorphic Labs, can predict the structures and interactions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results